- Home
- BMY vs MDT Comparison
BMY vs MDT Comparison
Compare BMY & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMY
- MDT
- Stock Information
- Founded
- BMY 1887
- MDT 1949
- Country
- BMY United States
- MDT Ireland
- Employees
- BMY N/A
- MDT N/A
- Industry
- BMY Biotechnology: Pharmaceutical Preparations
- MDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BMY Health Care
- MDT Health Care
- Exchange
- BMY Nasdaq
- MDT Nasdaq
- Market Cap
- BMY 120.5B
- MDT 109.2B
- IPO Year
- BMY N/A
- MDT N/A
- Fundamental
- Price
- BMY $46.98
- MDT $81.25
- Analyst Decision
- BMY Hold
- MDT Hold
- Analyst Count
- BMY 16
- MDT 16
- Target Price
- BMY $58.93
- MDT $94.73
- AVG Volume (30 Days)
- BMY 15.5M
- MDT 7.7M
- Earning Date
- BMY 04-24-2025
- MDT 05-21-2025
- Dividend Yield
- BMY 5.28%
- MDT 3.50%
- EPS Growth
- BMY N/A
- MDT 30.80
- EPS
- BMY 2.67
- MDT 3.61
- Revenue
- BMY $47,636,000,000.00
- MDT $33,537,000,000.00
- Revenue This Year
- BMY N/A
- MDT $5.38
- Revenue Next Year
- BMY N/A
- MDT $5.08
- P/E Ratio
- BMY $17.60
- MDT $22.50
- Revenue Growth
- BMY 4.62
- MDT 3.62
- 52 Week Low
- BMY $39.35
- MDT $75.96
- 52 Week High
- BMY $63.33
- MDT $96.25
- Technical
- Relative Strength Index (RSI)
- BMY 42.78
- MDT 39.18
- Support Level
- BMY $46.47
- MDT $79.93
- Resistance Level
- BMY $47.36
- MDT $88.28
- Average True Range (ATR)
- BMY 1.20
- MDT 1.51
- MACD
- BMY 0.32
- MDT -0.37
- Stochastic Oscillator
- BMY 67.42
- MDT 15.75
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About MDT Medtronic plc.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.